MEASUREMENT OF MDGF1 AND ITS RECEPTOR AS PROGNOSTIC VARIABLES IN BREAST CANCER
    45.
    发明申请
    MEASUREMENT OF MDGF1 AND ITS RECEPTOR AS PROGNOSTIC VARIABLES IN BREAST CANCER 审中-公开
    MDGF1及其受体作为乳腺癌预后变量的测定

    公开(公告)号:WO1993013416A1

    公开(公告)日:1993-07-08

    申请号:PCT/US1992011092

    申请日:1992-12-30

    CPC classification number: G01N33/6872 G01N33/57415

    Abstract: A method for detecting MDGF1 as a diagnostic or prognostic variable for breast cancer or other disease in a mammal, which comprises: a) contacting a portion of a tissue sample or body fluid from the mammal with one or more antibodies directed against MDGF1, and detecting the presence of MDGF1 by a quantitative assay, or b) detecting functional receptors in tissue membrane fractions by ligand binding and by determining phosphotyrosine accumulation on a specific protein, or both.

    Abstract translation: 一种用于检测MDGF1作为哺乳动物乳腺癌或其他疾病的诊断或预后变量的方法,其包括:a)使来自哺乳动物的组织样品或体液的一部分与一种或多种针对MDGF1的抗体接触,并检测 通过定量测定法存在MDGF1,或b)通过配体结合检测组织膜级分中的功能性受体并通过测定特异性蛋白上的磷酸酪氨酸积累,或两者兼有。

    PLATINUM COMPOUNDS SUITABLE FOR USE AS PHARMACEUTICALS
    50.
    发明申请
    PLATINUM COMPOUNDS SUITABLE FOR USE AS PHARMACEUTICALS 审中-公开
    适合用作药物的白蛋白化合物

    公开(公告)号:WO1989000575A1

    公开(公告)日:1989-01-26

    申请号:PCT/US1988002354

    申请日:1988-07-18

    CPC classification number: C07H23/00 C07F15/0093

    Abstract: Compounds of formula (I), wherein each of R1 and R2 is independently selected from the group consisting of halogen, hydroxy, or mono carboxylic acid or R1 and R2 together is a multifunctional carboxylic acid residue which forms a ring with the platinum atom through two oxygens of said multifunctional carboxylic acid; and R3 is a deoxy mono or disaccharide or a derivative thereof; and R4 is selected from the group consisting of hydrogen, C1-4-alkyl, phenyl, benzyl, substituted phenyl or substituted benzyl, wherein substituents are selected from the group consisting of halogen, nitro, C1-2-alkoxy, carboxy, carbonyl ester or phenyl or a pharmaceutically acceptable salt thereof are disclosed. Compositions containing these compounds and methods using these compounds are also discussed.

Patent Agency Ranking